Prognostic and clinicopathological value of CXCL12/SDF1 expression in breast cancer: A meta-analysis
ConclusionsThis present meta-analysis suggests that CXCL12/SDF1 protein expression is a good prognostic biomarker in breast cancer. In addition, the over-expression of CXCL12/SDF1 protein was associated with positive ER status, negative HER2 status and small tumor size.
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | HER2 | Science | Study